-
The sales policy of four types of epidemic monitoring drugs is loosened!
Time of Update: 2022-04-16
In order to strengthen the prevention and control of the new crown pneumonia epidemic, in early 2020, Guangdong Province took the lead in requiring all retail pharmacies to implement a registration and reporting system when selling fever and cough medicines.
-
"The first stock of HPV vaccine on the Hong Kong Stock Exchange" exploded!
Time of Update: 2022-04-16
Facing the blue ocean market, domestic HPV vaccine companies are on the rise, and several nine-valent pipelines have advanced to Phase III clinical trials.
. Whether it can occupy the first-mover advantage of the first domestic nine-valent HPV vaccine is very important for Ruike Bio .
-
Live Preview Solutions for Challenging APIs in Direct Pressure Processes
Time of Update: 2022-04-16
Solutions for Challenging APIs in Direct Pressure Processes Beijing time: Thursday, March 10, 2022 16:00-17:30 Live address: Click to register to participate activity descriptionThis webinar was conducted by technical experts from Budenheim, Germany, a preferential supplier, in a live online broadcast.
-
The whole process of traditional Chinese medicine decoction pieces can be traced back to the local pilot, and the non-traceable decoction pieces may be gradually abandoned, and the 100 billion market will be reshuffled!
Time of Update: 2022-04-16
Recently, Shanghai issued the "Notice on Carrying out the Pilot Work of Clinical Application of Whole-process Traceability of Traditional Chinese Medicine Pieces in the City", selected 5 well-known Chinese medicine hospitals and 8 pharmaceutical companies in Shanghai as pilots, supported the use of traceable pieces, and encouraged high quality and good prices.
-
[Dry goods] Analysis of the formulation process of generic drug quality standards
Time of Update: 2022-04-16
Selection of quality research items and preliminary determination of methods: It can be called the preliminary establishment of draft quality standards (this work should be completed before the compa
-
The first!
Time of Update: 2022-04-16
There are 5 TPO-R agonist drugs listed in China Primary immune thrombocytopenia (ITP) is a rare, severe autoimmune disorder characterized by low platelet counts in the blood that can lead to serious bleeding events .
-
Coron is on the hook!
Time of Update: 2022-04-16
Highlights Recently, Kelun Pharmaceutical has made new progress in research and development: the marketing application of troglitatin succinate tablets has entered the approval process, and the omega
-
Digitalization is coming, how do top pharmaceutical companies such as Merck, Pfizer, Sanofi, and Takeda come out on top in the competition?
Time of Update: 2022-04-16
As an established pharmaceutical company, Pfizer has shown great enthusiasm for digital transformation, and has made attempts in AI+ drug research and development, big data, digital marketing, and patient services .
-
Notice on Public Solicitation of Opinions on "<Technical Guidelines for Clinical Trials of Improved New Drugs of Chemical Drugs> Questions and Answers (Draft for Comments)"
Time of Update: 2022-04-16
pdf 2 Drafting Instructions for "Questions and Answers on Technical Guiding Principles for Clinical Trials of Improved New Drugs of Chemical Drugs (Draft for Comment)".
pdf 3 Questions and Answers on Technical Guiding Principles for Clinical Trials of Improved New Drugs of Chemical Drugs (Draft for Comment) Feedback Form.
-
CDE's new regulations speed up the launch of innovative drugs!
Time of Update: 2022-04-16
From the relevant requirements of the "Working Procedures", we can see that CDE strengthens the communication of the whole process, improves the efficiency of completing clinical trials, and focuses on supporting and accelerating the specific practice of high-value new drug research and development .
-
Yangzijiang grabbed the first imitation of Shugeng Sodium Glucose, and Cinda’s revenue was 4.2 billion and a loss of 3.1 billion
Time of Update: 2022-04-16
According to Yaohai data, the sales of the original research have grown rapidly since the launch, reaching nearly 300 million yuan last year .
According to data estimates, the sales in 2021 will be about 3 billion yuan, and the cumulative sales of the product since its launch will be about 6.
-
Brief analysis of centralized collection varieties: meropenem.
Time of Update: 2022-04-16
The market is not big, there are many snatchers Brief analysis of centralized collection varieties: Terbutaline inhalation .
There is no price, the market is difficult to guarantee Brief analysis of the collection varieties: methylprednisolone injection .
-
CDE publishes "Guidelines for Drug Registration Acceptance Review (Draft for Comment)"
Time of Update: 2022-04-16
On February 18, CDE issued the "Guidelines for the Acceptance and Review of Drug Registration (Trial) (Draft for Comment)", soliciting opinions on three aspects: traditional Chinese medicine, chemical drugs, and biological products.
-
just!
Time of Update: 2022-04-16
The competitive landscape of blood products is changing Open the prelude to the collection of biosimilar drugs Such a situation is a big challenge for Roche: In 2021, Roche's pharmaceutical business in China will generate US$3.
-
Good news - FACI magnesium stearate is activated!
Time of Update: 2022-04-16
Through these years of continuous development, Faci has gradually grown into a leader in the global oleochemical product market, and has established extensive and stable cooperative relations with customers in petrochemical, PVC, rubber, food, pharmaceutical, cosmetics and other industries.
-
BIPS 2nd Global Biomedical Innovation Pioneer China Summit 2022
Time of Update: 2022-04-16
·The summit includes two parallel forums, namely, the Pioneer Forum of Biomedical R&D Innovation and the Pioneer Forum of Biopharmaceutical Process Innovation .
-
50 major retail varieties are included in price monitoring!
Time of Update: 2022-04-16
In 2020, the total sales of acarbose tablets in Chinese public medical institutions and Chinese urban physical pharmacy terminals will exceed 5 billion yuan, and it is the best-selling oral hypoglycemic drug in China .
-
Huadong Medicine 2 major BD deals in 7 days!
Time of Update: 2022-04-16
Based on a number of BD transactions, Huadong Medicine has gradually formed a global ADC R&D ecosystem, and built a world-class independent R&D industry platform in the ADC field to continuously develop differentiated ADC innovative drugs .
-
Exclusive writing: Take your time when the original research of generic drugs replaces the project!
Time of Update: 2022-04-16
Judging from the performance of the hospital market, paclitaxel for injection (albumin-bound) exceeded 3 billion yuan for the first time in the fourth quarter of 2019, and the market size has also stabilized at about 3 billion yuan after entering the centralized procurement.
-
Whoever wins the new crown wins the world!
Time of Update: 2022-04-16
With the great success of the new crown vaccine product Spikevax, Moderna’s market value was close to $200 billion in August 2021, and it has more than 20 times in one year .
